Oregon State University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1868-10-27
- Employees
- 1K
- Market Cap
- -
- Website
- http://oregonstate.edu
WAVE~Ripples for Change: Obesity Prevention in Active Youth
Not Applicable
Completed
- Conditions
- Childhood Obesity Prevention
- Interventions
- Behavioral: Nutrition lessonsBehavioral: Virtual world learning environmentOther: Newsletter
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 498
- Registration Number
- NCT03215485
Exercise and Insulin Signaling in Human Skeletal Muscle
Not Applicable
Completed
- Conditions
- ObesityInsulin SensitivitySedentary Lifestyle
- Interventions
- Behavioral: Exercise
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 20
- Registration Number
- NCT02987491
- Locations
- 🇺🇸
Oregon State University, Corvallis, Oregon, United States
The Effect of Combinatorial Nutritional Supplementation on Immune Function in Healthy Older Adults
Not Applicable
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- Dietary Supplement: placeboDietary Supplement: Redoxon VI
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2022-12-01
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 42
- Registration Number
- NCT02876315
- Locations
- 🇺🇸
Oregon State University, Corvallis, Oregon, United States
Human Oral Detection of Glucose Olygomers
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 157
- Registration Number
- NCT02589353
- Locations
- 🇺🇸
Department of Food Science and Technology, Corvallis, Oregon, United States
Xanthohumol and Prevention of DNA Damage
Phase 1
Completed
- Conditions
- Oxidative Stress
- Interventions
- Drug: 6 mg xanthohumol per dayDrug: 12 mg xanthohumol per dayDrug: 24 mg xanthohumol per dayDrug: Placebo
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 64
- Registration Number
- NCT02432651
- Locations
- 🇺🇸
Oregon State University, Corvallis, Oregon, United States
Xanthohumol and Metabolic Syndrome
Completed
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: Xanthohumol
- First Posted Date
- 2011-06-07
- Last Posted Date
- 2015-07-24
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 48
- Registration Number
- NCT01367431
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8
Not Applicable
Completed
- Conditions
- ViolenceCharacterAcademic AchievementSubstance UsePro-Social Behavior
- Interventions
- Behavioral: Positive Action program
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 4230
- Registration Number
- NCT01025674
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸Oregon State University, Corvallis, Oregon, United States
The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease
Phase 2
- Conditions
- Atherosclerosis
- Interventions
- Dietary Supplement: R-alpha lipoic acid
- First Posted Date
- 2008-10-02
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 50
- Registration Number
- NCT00764270
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Lipoic Acid and Prevention of Heart Disease
Phase 2
- Conditions
- Atherosclerosis
- Interventions
- Dietary Supplement: R-alpha lipoic acidDietary Supplement: Placebo
- First Posted Date
- 2008-10-02
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 100
- Registration Number
- NCT00765310
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Empowering Patients to Better Manage Diabetes Through Self-Care
Phase 3
Completed
- Conditions
- Type I or Type II Diabetes (Excludes Gestational Diabetes)
- Interventions
- Behavioral: Pharmacist CounselingBehavioral: Educational materials
- First Posted Date
- 2005-11-16
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Oregon State University
- Target Recruit Count
- 69
- Registration Number
- NCT00254501
© Copyright 2025. All Rights Reserved by MedPath